ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,574.80
      0.14%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Entasis Therapeutics Holdings Inc (ETTX)

      7. Entasis Therapeutics Holdings Inc (ETTX) News

      ETTX

      Entasis Therapeutics (ETTX)

      Entasis Therapeutics Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ETTX
      DateTimeSourceHeadlineSymbolCompany
      10/12/20228:30AMGlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/21/20225:28PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:27PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:17PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:17PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:16PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:15PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:13PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20225:13PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/11/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/08/20225:05PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/08/20225:02PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/08/20224:55PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/08/20224:49PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/08/20228:35AMBusiness WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      07/01/20226:04AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      06/17/20228:11AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      06/17/20228:09AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      06/17/20228:04AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
      06/17/20227:58AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:ETTX